A Double-blind Trial of Lactobacillus paracasei Strain KW3110 Administration for Immunomodulation in Patients with Pollen Allergy

Our results suggest that ingestion of the L. paracasei strain KW3110 is associated with both repression of Th2 cell generation and eosinophil activation. Our data point to the possibility that specific lactic acid bacteria may be useful for allergy therapy.